TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
TCL Archive Draft FY 1993 Bypass Budget Seeks $2.7 Billion, Stabilization Of Groups, Centers, And Prevention May 10, 1991
